PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Franklin Biotechnology Discovery Fund (FBDIX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Fund Info

ISINUS3547138442
CUSIP354713844
IssuerFranklin Templeton Investments
Inception DateSep 14, 1997
CategoryHealth & Biotech Equities
Min. Investment$1,000
Asset ClassEquity

Asset Class Size

Large-Cap

Asset Class Style

Growth

Expense Ratio

FBDIX has a high expense ratio of 1.06%, indicating higher-than-average management fees.


Expense ratio chart for FBDIX: current value at 1.06% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.06%

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Franklin Biotechnology Discovery Fund

Popular comparisons: FBDIX vs. FSHCX

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Franklin Biotechnology Discovery Fund, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


400.00%600.00%800.00%1,000.00%1,200.00%December2024FebruaryMarchAprilMay
1,182.46%
456.25%
FBDIX (Franklin Biotechnology Discovery Fund)
Benchmark (^GSPC)

S&P 500

Returns By Period

Franklin Biotechnology Discovery Fund had a return of 6.69% year-to-date (YTD) and 20.59% in the last 12 months. Over the past 10 years, Franklin Biotechnology Discovery Fund had an annualized return of 6.88%, while the S&P 500 had an annualized return of 10.99%, indicating that Franklin Biotechnology Discovery Fund did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date6.69%11.18%
1 month3.87%5.60%
6 months30.35%17.48%
1 year20.59%26.33%
5 years (annualized)7.09%13.16%
10 years (annualized)6.88%10.99%

Monthly Returns

The table below presents the monthly returns of FBDIX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20244.83%8.01%-1.55%-6.54%6.69%
20235.35%-4.76%0.52%3.95%-3.44%1.43%2.78%-0.93%-3.48%-5.71%4.18%19.44%18.40%
2022-10.01%-3.70%4.67%-8.70%-6.72%3.56%3.19%0.08%-1.39%4.26%6.82%-3.72%-12.65%
20210.32%1.00%-6.70%0.92%-5.67%5.99%-5.34%5.07%-4.88%-1.52%-7.87%0.84%-17.45%
2020-4.57%0.79%-8.97%13.89%9.86%3.16%0.48%0.11%3.10%-4.23%11.74%3.53%29.85%
201914.11%4.94%-0.31%-4.96%-2.65%12.17%-4.18%-5.16%-5.66%11.29%10.36%3.49%34.99%
20186.05%-3.18%-2.53%-2.88%5.07%1.22%2.26%4.30%-1.59%-14.78%3.70%-12.15%-15.77%
20175.64%7.94%-1.07%0.65%-7.01%9.03%2.78%5.18%1.08%-7.79%-1.05%3.53%18.83%
2016-22.92%-6.37%4.60%3.81%5.98%-7.44%10.09%-1.49%5.61%-10.69%8.99%-3.31%-17.12%
20155.51%5.52%2.76%-5.47%10.01%0.55%2.06%-10.20%-12.45%5.96%4.29%-0.32%5.73%
201411.24%7.31%-10.61%-7.57%2.85%8.27%-0.97%12.70%-1.95%8.25%1.26%1.51%33.76%
20138.74%2.09%7.53%6.71%3.17%-1.00%15.81%-1.72%9.81%-6.00%6.75%3.39%68.70%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of FBDIX is 29, suggesting that the investment has average results relative to other mutual funds in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of FBDIX is 2929
FBDIX (Franklin Biotechnology Discovery Fund)
The Sharpe Ratio Rank of FBDIX is 2727Sharpe Ratio Rank
The Sortino Ratio Rank of FBDIX is 2828Sortino Ratio Rank
The Omega Ratio Rank of FBDIX is 2424Omega Ratio Rank
The Calmar Ratio Rank of FBDIX is 2929Calmar Ratio Rank
The Martin Ratio Rank of FBDIX is 3737Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Franklin Biotechnology Discovery Fund (FBDIX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


FBDIX
Sharpe ratio
The chart of Sharpe ratio for FBDIX, currently valued at 1.06, compared to the broader market-1.000.001.002.003.004.001.06
Sortino ratio
The chart of Sortino ratio for FBDIX, currently valued at 1.62, compared to the broader market-2.000.002.004.006.008.0010.0012.001.62
Omega ratio
The chart of Omega ratio for FBDIX, currently valued at 1.18, compared to the broader market0.501.001.502.002.503.003.501.18
Calmar ratio
The chart of Calmar ratio for FBDIX, currently valued at 0.51, compared to the broader market0.002.004.006.008.0010.0012.000.51
Martin ratio
The chart of Martin ratio for FBDIX, currently valued at 3.78, compared to the broader market0.0020.0040.0060.0080.003.78
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.38, compared to the broader market-1.000.001.002.003.004.002.38
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.37, compared to the broader market-2.000.002.004.006.008.0010.0012.003.37
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.42, compared to the broader market0.501.001.502.002.503.003.501.42
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.94, compared to the broader market0.002.004.006.008.0010.0012.001.94
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 9.12, compared to the broader market0.0020.0040.0060.0080.009.12

Sharpe Ratio

The current Franklin Biotechnology Discovery Fund Sharpe ratio is 1.06. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Franklin Biotechnology Discovery Fund with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00December2024FebruaryMarchAprilMay
1.06
2.38
FBDIX (Franklin Biotechnology Discovery Fund)
Benchmark (^GSPC)

Dividends

Dividend History

Franklin Biotechnology Discovery Fund granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to $0.00 per share.


PeriodTTM20232022202120202019201820172016201520142013
Dividend$0.00$0.00$0.14$17.68$24.84$14.16$4.55$3.60$5.93$13.78$6.67$8.79

Dividend yield

0.00%0.00%0.13%14.37%14.50%9.39%3.72%2.39%4.57%8.42%3.96%6.71%

Monthly Dividends

The table displays the monthly dividend distributions for Franklin Biotechnology Discovery Fund. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.14$0.14
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$17.68$17.68
2020$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$24.84$24.84
2019$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$14.16$14.16
2018$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$4.55$4.55
2017$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$3.60$3.60
2016$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$5.93$5.93
2015$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$13.78$13.78
2014$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$6.67$6.67
2013$8.79$8.79

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-40.00%-30.00%-20.00%-10.00%0.00%December2024FebruaryMarchAprilMay
-18.51%
-0.09%
FBDIX (Franklin Biotechnology Discovery Fund)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Franklin Biotechnology Discovery Fund. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Franklin Biotechnology Discovery Fund was 71.44%, occurring on Jul 10, 2002. Recovery took 2562 trading sessions.

The current Franklin Biotechnology Discovery Fund drawdown is 18.51%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-71.44%Mar 7, 2000584Jul 10, 20022562Sep 17, 20123146
-47.19%Feb 9, 2021339Jun 13, 2022
-42.19%Jul 20, 2015141Feb 8, 20161076May 18, 20201217
-35.19%May 11, 199881Aug 31, 1998226Jul 13, 1999307
-24.05%Feb 26, 201435Apr 15, 2014134Oct 24, 2014169

Volatility

Volatility Chart

The current Franklin Biotechnology Discovery Fund volatility is 4.98%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%8.00%December2024FebruaryMarchAprilMay
4.98%
3.36%
FBDIX (Franklin Biotechnology Discovery Fund)
Benchmark (^GSPC)